TFAP2A Gene

Name transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
Description The protein encoded by this gene is a transcription factor that binds the consensus sequence 5'-GCCNNNGGC-3'. The encoded protein functions as either a homodimer or as a heterodimer with similar family members. This protein activates the transcription of some genes while inhibiting the transcription of others. Defects in this gene are a cause of branchiooculofacial syndrome (BOFS). Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Dec 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nTFAP2A is a critical developmental transcription factor that orchestrates diverse morphogenetic processes. It regulates embryonic differentiation in craniofacial, ocular, cardiac, placental, and pigment cell lineages. Notably, mutations in TFAP2A are responsible for branchio‐oculo‐facial syndrome—manifesting as cleft lip, ocular anomalies, and inner ear defects—and its binding to regulatory elements (for example, those driving IRF6 expression) underlies proper facial and limb development. TFAP2A also modulates cardiac gene networks by repressing targets such as TBX20 and contributes to melanocyte differentiation by cooperating with key factors to activate pigmentation gene expression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the arena of tumorigenesis, TFAP2A often functions as a tumor suppressor. Its expression promotes cell cycle arrest and apoptosis, in part through cooperative interactions with p53 to induce p21 and sustain epithelial differentiation via activation of E‑cadherin. Reduced TFAP2A levels have been associated with metastatic progression in melanoma, colon cancer, and glioma, while its re‐expression can repress oncogenic targets such as Rad51 and modulate metastasis suppressors like KiSS‑1. These studies underscore that a loss of TFAP2A activity erodes normal transcriptional control mechanisms that would otherwise limit proliferation and invasion."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nParadoxically, TFAP2A can also assume oncogenic roles in a context‐dependent manner. In certain breast and lung cancers, for instance, it functions as a transcriptional activator—cooperating with factors such as YY1 to stimulate ERBB2 expression or upregulating effectors like KRT16 and heme oxygenase‑1—that promote epithelial–mesenchymal transition and metastasis. Similarly, in nasopharyngeal carcinoma, elevated TFAP2A drives pro‑angiogenic VEGF signaling through HIF‑1α mediation, while microRNA‑mediated suppression of TFAP2A has been shown to reduce HO‑1 levels and inhibit tumor growth. Such diverse, context‐specific activities exemplify the dualistic nature of TFAP2A in oncogenesis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nTFAP2A’s impact on gene expression is mediated by complex interactions with a wide array of co‑regulators and cis‑elements. It binds promoter regions directly and forms transcriptional complexes with proteins such as Sp1, p53, and nucleophosmin. Its activity is finely tuned by negative regulators like KCTD1 and by sequence variants that alter its binding efficiency, as seen in the regulation of genes involved in folate transport and detoxification (e.g. GSTM1) as well as those governing trophoblast invasion. These multifaceted regulatory interactions illustrate how TFAP2A integrates intrinsic developmental programs with extrinsic signals to control cellular differentiation and homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "31", "end_ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Micha Ben-Zimra, Moriah Koler, Joseph Orly "}, {"type": "b", "children": [{"type": "t", "text": "Transcription of cholesterol side-chain cleavage cytochrome P450 in the placenta: activating protein-2 assumes the role of steroidogenic factor-1 by binding to an overlapping promoter element."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2002-0056"}], "href": "https://doi.org/10.1210/me.2002-0056"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12145340"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12145340"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Stefanie Hammer, Martje Toenjes, Martin Lange, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of TBX20 in human hearts and its regulation by TFAP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.21686"}], "href": "https://doi.org/10.1002/jcb.21686"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18275040"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18275040"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jeff M Milunsky, Tom A Maher, Geping Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TFAP2A mutations result in branchio-oculo-facial syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2008.03.005"}], "href": "https://doi.org/10.1016/j.ajhg.2008.03.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18423521"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18423521"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Fedik Rahimov, Mary L Marazita, Axel Visel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.242"}], "href": "https://doi.org/10.1038/ng.242"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18836445"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18836445"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Mustafa Tekin, Asli Sirmaci, Berrin Yüksel-Konuk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A complex TFAP2A allele is associated with branchio-oculo-facial syndrome and inner ear malformation in a deaf child."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet A (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.a.32619"}], "href": "https://doi.org/10.1002/ajmg.a.32619"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19206157"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19206157"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jeff M Milunsky, Tom M Maher, Geping Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genotype-phenotype analysis of the branchio-oculo-facial syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet A (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.a.33783"}], "href": "https://doi.org/10.1002/ajmg.a.33783"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21204207"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21204207"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jiangchuan Ye, Nathan R Tucker, Lu-Chen Weng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2016.10.001"}], "href": "https://doi.org/10.1016/j.ajhg.2016.10.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27866707"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27866707"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Hannah E Seberg, Eric Van Otterloo, Stacie K Loftus, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1006636"}], "href": "https://doi.org/10.1371/journal.pgen.1006636"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28249010"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28249010"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Lisa A McPherson, Alexander V Loktev, Ronald J Weigel "}, {"type": "b", "children": [{"type": "t", "text": "Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M208924200"}], "href": "https://doi.org/10.1074/jbc.M208924200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12226108"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12226108"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Carmen Tellez, Marya McCarty, Maribelis Ruiz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M309159200"}], "href": "https://doi.org/10.1074/jbc.M309159200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12975361"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12975361"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Narendra Wajapeyee, Kumaravel Somasundaram "}, {"type": "b", "children": [{"type": "t", "text": "Cell cycle arrest and apoptosis induction by activator protein 2alpha (AP-2alpha) and the role of p53 and p21WAF1/CIP1 in AP-2alpha-mediated growth inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M305624200"}], "href": "https://doi.org/10.1074/jbc.M305624200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14551210"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14551210"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Qingjie Li, Roderick H Dashwood "}, {"type": "b", "children": [{"type": "t", "text": "Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M405025200"}], "href": "https://doi.org/10.1074/jbc.M405025200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15331612"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15331612"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Amy B Heimberger, Eric C McGary, Dima Suki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2005)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15671555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15671555"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Dianne C Mitchell, Maen Abdelrahim, Jinsheng Weng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M506245200"}], "href": "https://doi.org/10.1074/jbc.M506245200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16260418"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16260418"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Narendra Wajapeyee, Ramona Britto, Halasahalli M Ravishankar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Apoptosis induction by activator protein 2alpha involves transcriptional repression of Bcl-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M600539200"}], "href": "https://doi.org/10.1074/jbc.M600539200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16533807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16533807"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Carmen S Tellez, Darren W Davis, Victor G Prieto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during melanoma progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.jid.5700539"}], "href": "https://doi.org/10.1038/sj.jid.5700539"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16946713"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16946713"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "B Schwartz, V O Melnikova, C Tellez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1210193"}], "href": "https://doi.org/10.1038/sj.onc.1210193"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17224907"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17224907"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Hsuan Liu, Bertrand Chin-Ming Tan, Kai Hung Tseng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nucleophosmin acts as a novel AP2alpha-binding transcriptional corepressor during cell differentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO Rep (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.embor.7400909"}], "href": "https://doi.org/10.1038/sj.embor.7400909"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17318229"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17318229"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jonathan A F Hannay, Juehui Liu, Quan-Sheng Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-06-0636"}], "href": "https://doi.org/10.1158/1535-7163.MCT-06-0636"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17513613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17513613"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Joshua Z Rappoport, Sanford M Simon "}, {"type": "b", "children": [{"type": "t", "text": "Endocytic trafficking of activated EGFR is AP-2 dependent and occurs through preformed clathrin spots."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Sci (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/jcs.040030"}], "href": "https://doi.org/10.1242/jcs.040030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19351721"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19351721"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Vladislava O Melnikova, Andrey S Dobroff, Maya Zigler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0012452"}], "href": "https://doi.org/10.1371/journal.pone.0012452"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20805990"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20805990"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Wenhuan Huang, Zhe Zhong, Chang Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Theranostics (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/thno.33800"}], "href": "https://doi.org/10.7150/thno.33800"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31534499"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31534499"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Dominique Y Begon, Laurence Delacroix, Douglas Vernimmen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M503790200"}], "href": "https://doi.org/10.1074/jbc.M503790200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15870067"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15870067"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "XiaoJuan Sun, Jeffrey D Ritzenthaler, XiaoRong Zhong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alpha."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-09-1001"}], "href": "https://doi.org/10.1158/0008-5472.CAN-09-1001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19654299"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19654299"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Gaia Gestri, Robert J Osborne, Alexander W Wyatt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulators."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00439-009-0730-x"}], "href": "https://doi.org/10.1007/s00439-009-0730-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19685247"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19685247"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Dingbo Shi, Fangyun Xie, Yun Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TFAP2A regulates nasopharyngeal carcinoma growth and survival by targeting HIF-1α signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Prev Res (Phila) (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1940-6207.CAPR-13-0271"}], "href": "https://doi.org/10.1158/1940-6207.CAPR-13-0271"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24335623"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24335623"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Mengfan Pu, Chenggang Li, Xinming Qi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-1254 suppresses HO-1 expression through seed region-dependent silencing and non-seed interaction with TFAP2A transcript to attenuate NSCLC growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1006896"}], "href": "https://doi.org/10.1371/journal.pgen.1006896"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28749936"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28749936"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Damian Kołat, Żaneta Kałuzińska, Andrzej K Bednarek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20181928"}], "href": "https://doi.org/10.1042/BSR20181928"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30824562"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30824562"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Liu Yuanhua, Qian Pudong, Zhu Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TFAP2A Induced KRT16 as an Oncogene in Lung Adenocarcinoma via EMT."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijbs.34076"}], "href": "https://doi.org/10.7150/ijbs.34076"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31337972"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31337972"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Yanlu Xiong, Yangbo Feng, Jinbo Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TFAP2A potentiates lung adenocarcinoma metastasis by a novel miR-16 family/TFAP2A/PSG9/TGF-β signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-021-03606-x"}], "href": "https://doi.org/10.1038/s41419-021-03606-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33824285"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33824285"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Johnathan R Whetstine, Teah L Witt, Larry H Matherly "}, {"type": "b", "children": [{"type": "t", "text": "The human reduced folate carrier gene is regulated by the AP2 and sp1 transcription factor families and a functional 61-base pair polymorphism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M208296200"}], "href": "https://doi.org/10.1074/jbc.M208296200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12228234"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12228234"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Noriyuki Iwamoto, Sumiko Abe-Dohmae, Makoto Ayaori, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ATP-binding cassette transporter A1 gene transcription is downregulated by activator protein 2alpha. Doxazosin inhibits activator protein 2alpha and increases high-density lipoprotein biogenesis independent of alpha1-adrenoceptor blockade."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCRESAHA.107.151746"}], "href": "https://doi.org/10.1161/CIRCRESAHA.107.151746"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17556657"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17556657"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Xiaofeng Ding, Chang Luo, Jianlin Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The interaction of KCTD1 with transcription factor AP-2alpha inhibits its transactivation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.22002"}], "href": "https://doi.org/10.1002/jcb.22002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19115315"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19115315"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Ke-Da Yu, Gen-Hong Di, Lei Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.08-124073"}], "href": "https://doi.org/10.1096/fj.08-124073"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19228880"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19228880"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Katarzyna Biadasiewicz, Stefan Sonderegger, Peter Haslinger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcription factor AP-2α promotes EGF-dependent invasion of human trophoblast."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2010-0936"}], "href": "https://doi.org/10.1210/en.2010-0936"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21303946"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21303946"}]}]}]}
Synonyms AP-2ALPHA, BOFS, TFAP2, AP2TF, AP-2
Proteins AP2A_HUMAN
NCBI Gene ID 7020
API
Download Associations
Predicted Functions View TFAP2A's ARCHS4 Predicted Functions.
Co-expressed Genes View TFAP2A's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View TFAP2A's ARCHS4 Predicted Functions.

Functional Associations

TFAP2A has 12,052 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 138 datasets.

Click the + buttons to view associations for TFAP2A from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Achilles Cell Line Gene Essentiality Profiles cell lines with fitness changed by TFAP2A gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset.
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of TFAP2A gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of TFAP2A gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of TFAP2A gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of TFAP2A gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of TFAP2A gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of TFAP2A gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of TFAP2A gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of TFAP2A gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of TFAP2A gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of TFAP2A gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of TFAP2A gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with TFAP2A protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with TFAP2A gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of TFAP2A gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of TFAP2A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of TFAP2A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
ClinVar Gene-Phenotype Associations phenotypes associated with TFAP2A gene from the curated ClinVar Gene-Phenotype Associations dataset.
ClinVar Gene-Phenotype Associations 2025 phenotypes associated with TFAP2A gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of TFAP2A gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing TFAP2A protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing TFAP2A protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores cellular components containing TFAP2A protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing TFAP2A protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with TFAP2A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with TFAP2A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
CORUM Protein Complexes protein complexs containing TFAP2A protein from the CORUM Protein Complexes dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of TFAP2A gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with TFAP2A gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with TFAP2A gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with TFAP2A gene/protein from the curated CTD Gene-Disease Associations dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of TFAP2A protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by TFAP2A gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Curated Gene-Disease Association Evidence Scores diseases involving TFAP2A gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset.
DISEASES Curated Gene-Disease Association Evidence Scores 2025 diseases involving TFAP2A gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with TFAP2A gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with TFAP2A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with TFAP2A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with TFAP2A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with TFAP2A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at TFAP2A gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of TFAP2A gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of TFAP2A gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing TFAP2A from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with TFAP2A gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with TFAP2A gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of TFAP2A gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with TFAP2A gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing TFAP2A from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of TFAP2A gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of TFAP2A gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of TFAP2A gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of TFAP2A gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of TFAP2A gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of TFAP2A gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving TFAP2A gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving TFAP2A gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving TFAP2A gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing TFAP2A protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing TFAP2A protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing TFAP2A protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by TFAP2A gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by TFAP2A gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by TFAP2A gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of TFAP2A gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of TFAP2A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of TFAP2A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of TFAP2A gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of TFAP2A gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWAS Catalog SNP-Phenotype Associations phenotypes associated with TFAP2A gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with TFAP2A gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of TFAP2A gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of TFAP2A gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of TFAP2A gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of TFAP2A protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of TFAP2A gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HPO Gene-Disease Associations phenotypes associated with TFAP2A gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for TFAP2A from the curated Hub Proteins Protein-Protein Interactions dataset.
HuBMAP ASCT+B Annotations cell types associated with TFAP2A gene from the HuBMAP ASCT+B dataset.
HuBMAP ASCT+B Augmented with RNA-seq Coexpression cell types associated with TFAP2A gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset.
HuBMAP Azimuth Cell Type Annotations cell types associated with TFAP2A gene from the HuBMAP Azimuth Cell Type Annotations dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with TFAP2A gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for TFAP2A protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of TFAP2A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of TFAP2A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of TFAP2A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEA Substrates of Kinases kinases that phosphorylate TFAP2A protein from the curated KEA Substrates of Kinases dataset.
Kinase Library Serine Threonine Kinome Atlas kinases that phosphorylate TFAP2A protein from the Kinase Library Serine Threonine Atlas dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of TFAP2A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of TFAP2A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with TFAP2A gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of TFAP2A gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of TFAP2A gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of TFAP2A gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of TFAP2A gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing TFAP2A protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain TFAP2A protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by TFAP2A gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting TFAP2A gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of TFAP2A gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by TFAP2A gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Cancer Gene Co-expression Modules co-expressed genes for TFAP2A from the MSigDB Cancer Gene Co-expression Modules dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of TFAP2A gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of TFAP2A gene from the NIBR DRUG-seq U2OS MoA Box dataset.
NURSA Protein Complexes protein complexs containing TFAP2A protein recovered by IP-MS from the NURSA Protein Complexes dataset.
OMIM Gene-Disease Associations phenotypes associated with TFAP2A gene from the curated OMIM Gene-Disease Associations dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for TFAP2A from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of TFAP2A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of TFAP2A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving TFAP2A protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving TFAP2A protein from the Wikipathways PFOCR 2024 dataset.
Phosphosite Textmining Biological Term Annotations biological terms co-occuring with TFAP2A protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset.
PhosphoSitePlus Substrates of Kinases kinases that phosphorylate TFAP2A protein from the curated PhosphoSitePlus Substrates of Kinases dataset.
PID Pathways pathways involving TFAP2A protein from the PID Pathways dataset.
Reactome Pathways 2024 pathways involving TFAP2A protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of TFAP2A gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of TFAP2A gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of TFAP2A gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of TFAP2A gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of TFAP2A gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at TFAP2A gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of TFAP2A gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of TFAP2A gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with TFAP2A protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of TFAP2A gene from the Sci-Plex Drug Perturbation Signatures dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of TFAP2A gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of TFAP2A gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of TFAP2A gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of TFAP2A gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of TFAP2A gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of TFAP2A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of TFAP2A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of TFAP2A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of TFAP2A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with TFAP2A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with TFAP2A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving TFAP2A protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving TFAP2A protein from the WikiPathways Pathways 2024 dataset.